nodes	percent_of_prediction	percent_of_DWPC	metapath
Metaxalone—Anaphylactoid reaction—Aminophylline—chronic obstructive pulmonary disease	0.0313	0.0313	CcSEcCtD
Metaxalone—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.0289	0.0289	CcSEcCtD
Metaxalone—Tension—Roflumilast—chronic obstructive pulmonary disease	0.0268	0.0268	CcSEcCtD
Metaxalone—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.0265	0.0265	CcSEcCtD
Metaxalone—Irritability—Montelukast—chronic obstructive pulmonary disease	0.0215	0.0215	CcSEcCtD
Metaxalone—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.0208	0.0208	CcSEcCtD
Metaxalone—Tension—Aminophylline—chronic obstructive pulmonary disease	0.0179	0.0179	CcSEcCtD
Metaxalone—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.0177	0.0177	CcSEcCtD
Metaxalone—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.0174	0.0174	CcSEcCtD
Metaxalone—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.0169	0.0169	CcSEcCtD
Metaxalone—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.0168	0.0168	CcSEcCtD
Metaxalone—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.0164	0.0164	CcSEcCtD
Metaxalone—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.0163	0.0163	CcSEcCtD
Metaxalone—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.0149	0.0149	CcSEcCtD
Metaxalone—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.0147	0.0147	CcSEcCtD
Metaxalone—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.0142	0.0142	CcSEcCtD
Metaxalone—Rash—Roflumilast—chronic obstructive pulmonary disease	0.0141	0.0141	CcSEcCtD
Metaxalone—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.014	0.014	CcSEcCtD
Metaxalone—Headache—Roflumilast—chronic obstructive pulmonary disease	0.014	0.014	CcSEcCtD
Metaxalone—Tension—Arformoterol—chronic obstructive pulmonary disease	0.0136	0.0136	CcSEcCtD
Metaxalone—Tension—Formoterol—chronic obstructive pulmonary disease	0.0136	0.0136	CcSEcCtD
Metaxalone—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.0135	0.0135	CcSEcCtD
Metaxalone—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.0135	0.0135	CcSEcCtD
Metaxalone—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.0132	0.0132	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.0129	0.0129	CcSEcCtD
Metaxalone—Tension—Salbutamol—chronic obstructive pulmonary disease	0.0129	0.0129	CcSEcCtD
Metaxalone—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.0127	0.0127	CcSEcCtD
Metaxalone—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.0113	0.0113	CcSEcCtD
Metaxalone—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.0113	0.0113	CcSEcCtD
Metaxalone—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.0111	0.0111	CcSEcCtD
Metaxalone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.011	0.011	CcSEcCtD
Metaxalone—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.0107	0.0107	CcSEcCtD
Metaxalone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.0105	0.0105	CcSEcCtD
Metaxalone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.0103	0.0103	CcSEcCtD
Metaxalone—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.0101	0.0101	CcSEcCtD
Metaxalone—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.0101	0.0101	CcSEcCtD
Metaxalone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00992	0.00992	CcSEcCtD
Metaxalone—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00986	0.00986	CcSEcCtD
Metaxalone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00984	0.00984	CcSEcCtD
Metaxalone—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.0095	0.0095	CcSEcCtD
Metaxalone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00946	0.00946	CcSEcCtD
Metaxalone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00938	0.00938	CcSEcCtD
Metaxalone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00937	0.00937	CcSEcCtD
Metaxalone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00932	0.00932	CcSEcCtD
Metaxalone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00927	0.00927	CcSEcCtD
Metaxalone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00892	0.00892	CcSEcCtD
Metaxalone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00884	0.00884	CcSEcCtD
Metaxalone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00884	0.00884	CcSEcCtD
Metaxalone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00883	0.00883	CcSEcCtD
Metaxalone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00879	0.00879	CcSEcCtD
Metaxalone—Irritability—Prednisone—chronic obstructive pulmonary disease	0.00865	0.00865	CcSEcCtD
Metaxalone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00834	0.00834	CcSEcCtD
Metaxalone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00834	0.00834	CcSEcCtD
Metaxalone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00833	0.00833	CcSEcCtD
Metaxalone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00817	0.00817	CcSEcCtD
Metaxalone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00801	0.00801	CcSEcCtD
Metaxalone—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00801	0.00801	CcSEcCtD
Metaxalone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00787	0.00787	CcSEcCtD
Metaxalone—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00784	0.00784	CcSEcCtD
Metaxalone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00756	0.00756	CcSEcCtD
Metaxalone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00749	0.00749	CcSEcCtD
Metaxalone—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00749	0.00749	CcSEcCtD
Metaxalone—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00733	0.00733	CcSEcCtD
Metaxalone—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.0072	0.0072	CcSEcCtD
Metaxalone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.0072	0.0072	CcSEcCtD
Metaxalone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00714	0.00714	CcSEcCtD
Metaxalone—Rash—Formoterol—chronic obstructive pulmonary disease	0.00714	0.00714	CcSEcCtD
Metaxalone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00713	0.00713	CcSEcCtD
Metaxalone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00713	0.00713	CcSEcCtD
Metaxalone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00709	0.00709	CcSEcCtD
Metaxalone—Headache—Formoterol—chronic obstructive pulmonary disease	0.00709	0.00709	CcSEcCtD
Metaxalone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00707	0.00707	CcSEcCtD
Metaxalone—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00705	0.00705	CcSEcCtD
Metaxalone—Rash—Montelukast—chronic obstructive pulmonary disease	0.00699	0.00699	CcSEcCtD
Metaxalone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00698	0.00698	CcSEcCtD
Metaxalone—Headache—Montelukast—chronic obstructive pulmonary disease	0.00695	0.00695	CcSEcCtD
Metaxalone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.0068	0.0068	CcSEcCtD
Metaxalone—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00674	0.00674	CcSEcCtD
Metaxalone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00673	0.00673	CcSEcCtD
Metaxalone—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00672	0.00672	CcSEcCtD
Metaxalone—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00672	0.00672	CcSEcCtD
Metaxalone—Headache—Salbutamol—chronic obstructive pulmonary disease	0.0067	0.0067	CcSEcCtD
Metaxalone—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00659	0.00659	CcSEcCtD
Metaxalone—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00635	0.00635	CcSEcCtD
Metaxalone—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00613	0.00613	CcSEcCtD
Metaxalone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00452	0.00452	CcSEcCtD
Metaxalone—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00445	0.00445	CcSEcCtD
Metaxalone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00405	0.00405	CcSEcCtD
Metaxalone—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00387	0.00387	CcSEcCtD
Metaxalone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00386	0.00386	CcSEcCtD
Metaxalone—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00384	0.00384	CcSEcCtD
Metaxalone—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00364	0.00364	CcSEcCtD
Metaxalone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00328	0.00328	CcSEcCtD
Metaxalone—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.00315	0.00315	CcSEcCtD
Metaxalone—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00295	0.00295	CcSEcCtD
Metaxalone—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00283	0.00283	CcSEcCtD
Metaxalone—Rash—Prednisone—chronic obstructive pulmonary disease	0.00281	0.00281	CcSEcCtD
Metaxalone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00281	0.00281	CcSEcCtD
Metaxalone—Headache—Prednisone—chronic obstructive pulmonary disease	0.00279	0.00279	CcSEcCtD
Metaxalone—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00265	0.00265	CcSEcCtD
